There's some nice movement occurring here lately. I think this is one of most undervalued stocks in the biopharma arena. If they get their manufacturing kinks worked out and have a drug that is effective against Parkinson's disease, this will no longer be selling at $2.95.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.